Customer support: Please contact Customer Support at 8008501437 with any question or issue related to PfizerPro sign up / sign in.
Representatives are available Sunday through Thursday, 9:00 am to 5:00 pm Saudi Local Time.

This site is intended for healthcare professionals in Saudi Arabia

Search

Menu

Close

Sign In / RegisterSign OutOur MedicinesTherapy AreasExplore ContentEvents HubMaterialsVideosOvid DicoveryLet's ConnectContact UsMedical Inquiries

       Adverse event reporting can be found at the bottom of the page

Menu

Close

About Prevenar 20™ at a Glance Serotype Coverage Pneumococcal Disease Clinical Programme RecommendationsPractical Use Videos & Resources Videos
Click here for Prevenar 20® Prescribing Information
Deliver the broadest serotype coverage for babies1-3Prevenar 20® helps protect against the 20 Streptococcus pneumoniae serotypes in the vaccine1
Discover expanded serotype coverage
LoadingRecommended by ACIP for healthy babies, preterm infants, and children at increased risk for invasive pneumococcal disease1,6 Learn more LoadingDemonstrated robust immune response against 20 serotypes after 4 doses with a safety profile comparable to Prevenar 13®1 Review trial results LoadingReferences:References:1. Prevenar 20® (Pneumococcal 20-valent Conjugate Vaccine). Summary of product characteristics. Saudi Arabia. Revision date: March 2024.
2. Prevenar 13® (Pneumococcal 13-valent Conjugate Vaccine). Summary of product characteristics. Saudi Arabia. Revision date: October 2021.
3. Vaxneuvance™ (Pneumococcal 15-valent Conjugate Vaccine). [Summary of Product Characteristics]. Merck Sharp & Dohme Corp. 2024. 
4. U.S. FDA approves PREVNAR 20®, Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for infants and children. (n.d.). Pfizer.com. https://www.pfizer.com/news/press-release/press-release-      detail/us-fda-approves-prevnar-20r-pfizers-20-valent-pneumococcal
5. van der Linden M, Perniciaro S, Imöhl M. Invasive pneumococcal disease among children in Germany, ten years after PCV13 introduction. Abstract P0325 presented online at: The European          Society for Paediatric Infectious Diseases 2020 Virtual Meeting; October 28, 2020.
6. CDC, ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children https://www.cdc.gov/mmwr/volumes/72/wr/mm7239a5.htm 
7. Al-Hajjaj, M., Alharbi, N. S., Al-Barrak, A. M., Al-Moamary, M. S., Zeitouni, M. O., Idrees, M. M., Al-Ghobain, M. O., & Al-Shimemeri, A. A. (2016). The Saudi Thoracic Society pneumococcal            vaccination guidelines-2016. Annals of Thoracic Medicine, 0(0), 0. https://doi.org/10.4103/1817-1737.177470
PP-PNR-SAU-0092

Report Adverse Events

Please send us an email if you want to report an adverse event, email your enquiry to [email protected]

Pfizerpro account

Access Pfizer materials, resources and receive communications from Pfizer about our products with a Pfizerpro account.

Sign In or RegisterPlease click here to contact Pfizer customer support.

Representatives are available Sun -Thu | 9 AM - 5 PM, excluding public holidays.

Copyright © 2025 Pfizer Inc. All rights reserved.

For Health Care Professionals Only

This information is intended only for Healthcare professionals in Saudi Arabia. The product information provided in this site is intended only for Healthcare professionals in Saudi Arabia. The products discussed herein may have different product labeling in different countries. Pfizer Inc does not suggest or recommend the use of Pfizer products in any manner other than as described in the Prescribing information approved by Saudi Food and Drug Administration (SFDA). Pfizer Scientific Technical Limited Company is a subsidiary of Pfizer Inc., a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
PP-UNP-SAU-1192
You are now leaving PfizerPro​​​​​

You are leaving the Pfizer Portal - Would you like to continue?​​​​​​​